Concepedia

Mark Sheehan

MS

Statistics

Publications

4

Citations

297

H-Index

4

Active since

2017

Affiliations

Pfizer (United States)(Current)

Mark Sheehan is an author at Pfizer (United States) specializing in neuroscience, molecular neuroscience, and molecular biology.

ORCID

Publications per year

2017–2024

4

Publications

4

Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder

Thomas A. Lanz, Veronica Reinhart, Mark Sheehan et al. · Translational Psychiatry · 2019 · 188 citations · Full text

, , +14

Inhibition of monoacylglycerol lipase terminates diazepam‐resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet

Gaetano Terrone, Alberto Pauletti, Alessia Salamone et al. · Epilepsia · 2017 · 57 citations · Full text

, , +17

mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditions

Hong-My Nguyen, Kristin E. Alexander, Mark Collinge et al. · Molecular Therapy · 2024 · 32 citations · Full text

, , +16

Comparing molecular and computational approaches for detecting viral integration of AAV gene therapy constructs

Elias M. Oziolor, Steven W. Kumpf, Jessie Qian et al. · Molecular Therapy — Methods & Clinical Development · 2023 · 20 citations · Full text

, , +14

1–4 of 4